Mantle Cell Lymphoma (MCL) Terminated Phase 2 Trials for Fludarabine (DB01073)

Also known as: Mantle Cell Lymphomas / Lymphoma, Mantle-Cell / Mantle-Cell Lymphoma / Lymphoma, Mantle Cell / Mantle Cell Lymphoma / B cell lymphoma / Centrocytic lymphoma / Mantle cell lymphoma NOS

IndicationStatusPhase
DBCOND0071979 (Mantle Cell Lymphoma (MCL))Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01578343Vorinostat Plus FND in Relapsed or Refractory Mantle Cell LymphomaTreatment
NCT00183989Combination Therapy With Fludarabine, Mitoxantrone and Rituximab in Mantle Cell LymphomaTreatment